SPONSOR
NYU Langone Health
Total Trials
21
Recruiting
21
Phases
Phase 2, EARLY_Phase 1, Phase 1, Phase 2, Phase 4, Phase 1
Conditions studied: Hearing ImpairmentGenetic TestingHearing LossSeizuresSeizure DisorderPsychogenic Movement DisorderInflammatory Bowel DiseasesHeart TransplantationDepressionAnxiety
NYU Langone Health is a clinical research sponsor with 21 registered studies on ClinicalTrials.gov, of which 21 are actively recruiting participants. Research covers conditions including Hearing Impairment, Genetic Testing, Hearing Loss, Seizures.
The trial portfolio spans Phase 2, EARLY_Phase 1, Phase 1, Phase 2 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — NYU Langone Health
How many clinical trials has NYU Langone Health sponsored?
ClinicalMetric currently tracks 21 clinical trials sponsored by NYU Langone Health, of which 21 are actively recruiting participants. These trials cover conditions including Hearing Impairment, Genetic Testing, Hearing Loss. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does NYU Langone Health research focus on?
NYU Langone Health clinical trials span Hearing Impairment, Genetic Testing, Hearing Loss, Seizures, Seizure Disorder, and additional conditions. The research pipeline includes Phase 2, EARLY_Phase 1, Phase 1, Phase 2 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a NYU Langone Health clinical trial?
To participate in a NYU Langone Health trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all NYU Langone Health trials with current recruitment status updated daily.
Clinical Trials by NYU Langone Health
NCT06663917
Recruiting
Clinical Evaluation of Frequency Allocation for Bimodal CI Users
Hearing Impairment
NCT06926816
Recruiting
Universal Genetic Testing for Cancer Risk Reduction
Genetic Testing
NCT07011927
Recruiting
Extra-cochlear Electrode Placement at the Post-auricular Vagus Nerve in Cochlear Implantation
Hearing Loss
NCT03233399
Recruiting
Modulating Movement Intention Via Cortical Stimulation
Seizures
NCT06309017
Recruiting
Pre-operative Nutrition for Elective Resection Surgery in Inflammatory Bowel Disease
Inflammatory Bowel Diseases
NCT04477629 Phase 2
Recruiting
Belatacept in De Novo Heart Transplantation
Heart Transplantation
NCT06004414
Recruiting
SilverCloud as a School-Based Intervention for Vulnerable Youth
Depression
NCT07525635 EARLY_Phase 1
Recruiting
Aspirin Dosing in Pregnancy
Preeclampsia Possible
NCT07612215 Phase 1, Phase 2
Recruiting
Elacestrant in Advanced Triple Positive Breast Cancer
ER Positive, HER2 Positive Breast Cancer
NCT05675735
Recruiting
Leveraging Regulatory Flexibility for Methadone Take-Home Dosing to Improve Retention in Treatment for Opioid Use Disorder
Problems Related to Social Environment
NCT05004987 Phase 4
Recruiting
Aβ Dynamics in LLMD
Alzheimer Disease
NCT06520579
Recruiting
Anterior Cervical Discectomy and Fusion (ACDF) - Behavioral Intervention
Dysphagia
NCT07184957
Recruiting
Prospective Database of Clinical Outcomes Following Cryotherapy for Ablation of Clinically Localized Prostate Cancer
Prostate Cancer
NCT06829173 EARLY_Phase 1
Recruiting
Concurrent XRD-0394 With Radiation Therapy for High Grade Gliomas
High-Grade Glioma
NCT07190170
Recruiting
Time Restricted Eating for WeIght LoSs MainTenance-2
Weight Loss
NCT06961630 EARLY_Phase 1
Recruiting
Post-Operative Biomarker-Guided Precision Medicine For Cardiovascular Risk Reduction
Myocardial Injury After Noncardiac Surgery
NCT03215719 Phase 2
Recruiting
Adaptive Treatment De-escalation in Favorable Risk HPV-Positive Oropharyngeal Carcinoma
Oropharyngeal Carcinoma
NCT05391828
Recruiting
Persona MC vs PS RCT With ROSA
Total Knee Arthroplasty
NCT07138898 Phase 2
Recruiting
Immunosuppressant Management in Rheumatology Patients Undergoing Elective Total Shoulder Arthroplasty
Rheumatic Disease
NCT05841784
Recruiting
HARP Mindfulness Study
Cardiovascular Diseases
NCT06455514 Phase 1
Recruiting
Post-CA Neuroprotection With Magnesium
Cardiac Arrest
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: September 2026 · Data Methodology